Bulimia Nervosa Market

Global Bulimia Nervosa Market research report, by treatment (psychotherapy, drug therapy and other) - Forecast Till 2023

Market Scenario:

Bulimia nervosa is also called as bulimia. It is an eating disorder characterised by eating large amount of food in short period of time. On global scale bulimia nervosa is increasing continuously. Factors like alcoholism, diabetes and cardiovascular diseases are responsible for causing bulimia nervosa. The major driving factor for the market is increasing prevalence of diseases like diabetes, cardiovascular diseases and psychic diseases. On other hand high cost of therapy can hamper the growth of the market.

Global bulimia nervosa market is expected to grow at a CAGR of 4.5% during forecasted period 2017-2023.

Study Objectives global bulimia nervosa market

• Detail information about the factors affecting the growth of the global bulimia nervosa market.


• Detail analysis of parent market with respect to all the possible segmentation of the market.


• Detail analysis of emerging key players for the market with their effective strategies.


• Detail Information about the present and forecasted market and factors that influences the market on global scale.


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global bulimia nervosa market.


• Analysis of the market of the different factors like- price analysis, supply chain analysis, porters five force analysis etc.


• Detail information on the possible segments and sub segments of the market. And regional analysis of the market- North America, Europe, Asia Pacific and Middle East and Africa.


• Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped


• Detail information on trends and the opportunities in various regions.

Figure 1- Global bulimia nervosa market share, by region

Key players for global bulimia nervosa market

Siemens Healthcare GmbH (Germany), Philips Healthcare (U.S), Abbott (U.S), Johnson & Johnson Services, Inc.(U.S), Stryker (U.S), General Electric Company (U.K), Covidien ltd(Ireland), Penumbra, Inc. (U.S) 

Segmentation

Global bulimia nervosa market is segmented into type of treatment into psychotherapy, drug therapy and other. Psychotherapy is further sub segmented into maudsley family therapy and other. Drug therapy is further sub segmented into antidepressants and other.

Regional Analysis

On regional basis, global bulimia nervosa market is dominated by North America. Due to increasing incident of bulimia nervosa in North America the market is grown significantly. Europe has a second largest market for the bulimia nervosa this is because of the governmental support and well developed healthcare sector. Asia Pacific is expected to grow at the fastest rate due to huge population base in this region.

Market Assessment

The report for global bulimia nervosa market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Intended Audience

• Pharmaceutical companies


• Bulimia Nervosa treatment centers


• Research and Development (R&D) Companies


• Government and Independent Research Laboratories


• Contract Research Organizations (CROs)


• Medical Research Laboratories


• Academic Medical Institutes and Universities